Patent · US Expired

Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof

US7153678B2 · kind B2 · utility

11Cited by
2References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2001
Grant dateDec 26, 2006
Priority date
Expiry dateDec 24, 2023

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A90/10
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides novel polynucleotides encoding human phosphatase polypeptides, fragments and homologues thereof. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel human phosphatase polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides, particularly cardiovascular diseases and/or disorders. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.